The New York University Program in Neuro-Ophthalmology is dedicated to providing the highest quality of medical care to patients with disorders affecting vision and the nervous system, regardless of financial, ethnic or social status, and to providing a forum for education and research into the causes and cure of visual dysfunction related to neurologic disease.
The NYU Department of Neurology is undergoing rapid growth with the recent addition of Steven L. Galetta, MD, Philip K. Moskowitz, MD, Professor and Chair of Neurology, and Laura J. Balcer, MD, MSCE, Professor and Vice Chair of Neurology. The Department currently serves patients from all five boroughs of New York, as well as Long Island, Connecticut, and New Jersey. The Department of Neurology, including the Multiple Sclerosis (MS) Center, serves thousands of patients annually. MS, an important platform for the study and treatment of neuro-ophthalmologic disease, is a key area served by neurology at NYU; the MS Center is one of the largest in the metropolitan New York area and in the United States.
The Department of Neurology is located at the NYU Ambulatory Care Center (ACC) at 240 East 38th Street, 15th Floor. The Department currently occupies approximately 5,000 square feet of newly-renovated, state-of-the-art space. In late 2013, the Department will be located in dedicated, newly-renovated space that will occupy the entire 20th floor of the ACC. Within the ~10,000 square feet of space on the 20th floor, designed with extensive input from Drs. Galetta and Balcer, there will be three examination rooms completely outfitted with specialized equipment for neuro-ophthalmologic testing. Approximately 500 square feet of vision research and neuro-ophthalmic testing space will also be present, including specialized rooms for optical coherence tomography (OCT) scanning, non-mydriatic ocular photography, and visual field testing. Three faculty offices and a fellows’ room for academic and clinically oriented reading and computer work will also be included in the Department of Neurology space.
Department of Neurology and Ophthalmology physicians are credentialed at all NYU component facilities. Consultation services are provided for patients at Tisch and Bellevue Hospitals.
The Neuro-Ophthalmology Program at NYU Langone Medical Center bridges the fields of neurology and ophthalmology through diagnosis and management of patients with neurological disorders that affect vision and eye movements. With three full-time faculty, NYU Neuro-Ophthalmology is now one of the larger programs in the U.S. and is led by physicians with national and international reputations for research and clinical care. Several of Dr. Galetta and Balcer’s fellows and other trainees have won national awards for presentations at the North American Neuro-Ophthalmology Society (NANOS) and American Academy of Ophthalmology (AAO). A major goal of the NYU Neuro-Ophthalmology fellowship will be to train excellent clinicians, physician-scientists, and, most importantly, future leaders in the field.
The Neuro-Ophthalmology program serves all patients, regardless of ethnicity, social status, financial means or insurance. All major insurance carriers are accepted, in addition to Medicare and Medicaid.
By virtue of its location in lower Manhattan, NYU Langone Medical Center Ambulatory Care Center (ACC) serves a diverse population of patients. A full range of Spanish literature is provided, and translators are available into numerous languages. In part because of these factors, the NYU MS Center is the foremost provider of MS services to minorities in metropolitan New York, adding to the world-class and diverse experience of patient care and research that characterizes NYU’s programs.
Clinical research in Neuro-Ophthalmology is a signature focus of the fellowship training program. Drs. Galetta and Balcer have led multi-center collaborative research efforts to develop visual function and ocular imaging (OCT) outcome measures for MS clinical trials. This work is funded by the National MS Society and the NIH/ National Eye Institute (including a K24 grant for mentoring trainees in patient-oriented research). They are also currently leading an international clinical trial of a neuro-repair agent for MS using acute optic neuritis as the model for structure-function correlations. The group has also developed collaborative research projects to test vision-based methods of assessment as sideline tools for sports-related concussion; these projects are active at local and national levels. The laboratory of Dr. James Salzer provides one of many outstanding and world-class neuroscience investigative groups in which fellows in Neuro-Ophthalmology can learn the basics of the scientific method and perform research directly related to the visual pathway.
Laura J. Balcer, M.D., M.S.C.E., Professor and Vice Chair, Department of Neurology; Director, Neuro-Ophthalmology Program in Neurology
Steven L. Galetta, M.D., Philip K. Moskowitz, MD, Professor and Chair of Neurology
Floyd A. Warren, M.D., Clinical Professor, Department of Ophthalmology; Director, Neuro-Ophthalmology Program in Ophthalmology
Joseph Herbert, M.D., Associate Professor of Neurology, Director, MS Center
Mohammad Fouladvand, M.D., Clinical Associate Professor